BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27569286)

  • 1. LMO2 blocks the UBA6-USE1 interaction and downstream FAT10ylation by targeting the ubiquitin fold domain of UBA6.
    Wu C; Liu Y; Gu X; Zhu T; Yang S; Sun W
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1442-8. PubMed ID: 27569286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
    Aichem A; Catone N; Groettrup M
    FEBS J; 2014 Apr; 281(7):1848-59. PubMed ID: 24528925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J; Groettrup M; Aichem A
    PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10.
    Wang F; Zhao B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.
    Aichem A; Kalveram B; Spinnenhirn V; Kluge K; Catone N; Johansen T; Groettrup M
    J Cell Sci; 2012 Oct; 125(Pt 19):4576-85. PubMed ID: 22797925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
    Aichem A; Pelzer C; Lukasiak S; Kalveram B; Sheppard PW; Rani N; Schmidtke G; Groettrup M
    Nat Commun; 2010 May; 1():13. PubMed ID: 20975683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1.
    Mueller S; Bialas J; Ryu S; Catone N; Aichem A
    PLoS One; 2023; 18(8):e0290002. PubMed ID: 37578983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic studies on activation of ubiquitin and di-ubiquitin-like protein, FAT10, by ubiquitin-like modifier activating enzyme 6, Uba6.
    Gavin JM; Chen JJ; Liao H; Rollins N; Yang X; Xu Q; Ma J; Loke HK; Lingaraj T; Brownell JE; Mallender WD; Gould AE; Amidon BS; Dick LR
    J Biol Chem; 2012 May; 287(19):15512-22. PubMed ID: 22427669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions.
    Schnell L; Zubrod A; Catone N; Bialas J; Aichem A
    Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37604583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAT10 : Activated by UBA6 and Functioning in Protein Degradation.
    Pelzer C; Groettrup M
    Subcell Biochem; 2010; 54():238-46. PubMed ID: 21222287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative ubiquitin activation/conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins.
    Lee PC; Sowa ME; Gygi SP; Harper JW
    Mol Cell; 2011 Aug; 43(3):392-405. PubMed ID: 21816346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus.
    Sugimoto A; Abe Y; Watanabe T; Hosokawa K; Adachi J; Tomonaga T; Iwatani Y; Murata T; Fujimuro M
    J Virol; 2021 Apr; 95(10):. PubMed ID: 33627385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Uba6-Specific-E2 (USE1) With Lung Tumorigenesis.
    Kim SJ; Hyeong Lee T; Hee Nam S; Kim JH; Oh S; Sook Cho Y; Sup Lee M; Choi S; Lee PC
    J Natl Cancer Inst; 2017 Mar; 109(3):1-11. PubMed ID: 28376205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging.
    Jin J; Li X; Gygi SP; Harper JW
    Nature; 2007 Jun; 447(7148):1135-8. PubMed ID: 17597759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of UBA6 explain its dual specificity for ubiquitin and FAT10.
    Truongvan N; Li S; Misra M; Kuhn M; Schindelin H
    Nat Commun; 2022 Aug; 13(1):4789. PubMed ID: 35970836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
    Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
    Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery.
    Schelpe J; Monté D; Dewitte F; Sixma TK; Rucktooa P
    J Biol Chem; 2016 Jan; 291(2):630-9. PubMed ID: 26555268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthogonal ubiquitin transfer identifies ubiquitination substrates under differential control by the two ubiquitin activating enzymes.
    Liu X; Zhao B; Sun L; Bhuripanyo K; Wang Y; Bi Y; Davuluri RV; Duong DM; Nanavati D; Yin J; Kiyokawa H
    Nat Commun; 2017 Jan; 8():14286. PubMed ID: 28134249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
    Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
    J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating the ubiquitin family: UBA6 challenges the field.
    Groettrup M; Pelzer C; Schmidtke G; Hofmann K
    Trends Biochem Sci; 2008 May; 33(5):230-7. PubMed ID: 18353650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.